세계의 변비 치료 시장 보고서(2025년)

Constipation treatment encompasses various methods and strategies aimed at alleviating and managing the condition, characterized by irregular or challenging bowel movements, often resulting in hard or dry stools. These treatments aim to address symptoms and promote regularity in bowel function.

The primary therapeutic approaches for treating constipation include various categories such as laxatives, chloride channel activators, peripherally acting mu-opioid receptor antagonists, GC-C (guanylate cyclase-c) agonists, and other related remedies. Laxatives, for instance, facilitate the passage of stool in the intestines, aiding in constipation treatment by enhancing stool size, frequency, and motility. They are commonly utilized in managing chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C), and opioid-induced constipation (OIC). These treatments are made available through multiple distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacy platforms.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The constipation treatment market research report is one of a series of new reports from The Business Research Company that provides constipation treatment market statistics, including constipation treatment industry global market size, regional shares, competitors with a constipation treatment market share, detailed constipation treatment market segments, market trends and opportunities, and any further data you may need to thrive in the constipation treatment industry. This constipation treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The constipation treatment market size has grown strongly in recent years. It will grow from $11.72 billion in 2024 to $12.36 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to the rising prevalence of digestive disorders, demographic changes, lifestyle factors, limited treatment options, and increasing awareness of health issues.

The constipation treatment market size is expected to see strong growth in the next few years. It will grow to $16.55 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to rising healthcare expenditure, increased focus on preventive healthcare, focus on pediatric constipation, growing demand for personalized healthcare solutions, the rise of telemedicine, expansion of e-commerce, focus on functional foods and probiotics. Major trends in the forecast period include technological advancements in healthcare, artificial intelligence and machine learning in healthcare, focus on sustainability and eco-friendly products, collaboration between healthcare providers and technology companies, and increased investment in R&D by pharmaceutical companies.

The forecast of 7.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose challenges for U.S. gastroenterology by restricting access to prescription laxatives and biofeedback therapy devices imported from the UK and France, potentially prolonging symptoms and increasing gastrointestinal(GI) clinic visits. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The upward trend in the consumption of fast food is anticipated to drive the growth of the constipation treatment market. Fast food, characterized by its quick preparation and service, often lacks sufficient fiber and tends to be high in fat and salt, contributing to constipation-related issues. As reported in August 2023 by Budget Branders, a US-based provider of paper and plastic products, the global market value of the fast food industry is projected to reach $931.7 billion by 2027. The US alone boasts over 200,000 distinct fast-food outlets, with consumers annually spending a staggering $200 billion on fast food. This surge in fast-food consumption underlines the growing need for constipation treatment solutions.

The increasing incidence of gastrointestinal disorders is expected to drive the growth of the constipation treatment market in the future. Gastrointestinal disorders, commonly known as digestive disorders, include a range of conditions affecting the digestive tract. Constipation is a frequent symptom associated with many gastrointestinal (GI) disorders. The rising prevalence of gastrointestinal disorders, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), is propelling the growth of the constipation treatment market, as these conditions often occur alongside constipation, creating a greater demand for specific and effective treatments amid heightened awareness. For instance, in January 2024, the American Cancer Society, a US-based non-profit organization, projected approximately 26,890 new cases of stomach cancer in the U.S. for 2024, with 16,160 cases in men and 10,730 in women. This type of cancer is also expected to result in around 10,880 deaths, including 6,490 men and 4,390 women. Therefore, the rising incidence of gastrointestinal disorders is driving the growth of the constipation treatment market.

Product innovation emerges as a pivotal trend gaining traction in the constipation treatment market. Companies operating in this market are strategically focusing on developing novel products to fortify their market position. A notable example is Ardelyx, a US-based biopharmaceutical company, which introduced IBSRELA in April 2022. IBSRELA represents a breakthrough treatment for irritable bowel syndrome with constipation (IBS-C) in adults, being the first-in-class therapy developed in over a decade. This innovative medication addresses symptoms such as constipation, bloating, and stomach pain, offering a substantial new treatment option for individuals affected by IBS-C.

Major players in the constipation treatment market are actively engaged in the development of groundbreaking products, including ready-to-drink suspensions, aiming to cater to a broader customer base, drive increased sales, and boost overall revenue. For instance, in October 2022, Navamedic ASA, a Norway-based pharmaceutical company, unveiled ForlaxGo. This unique product serves as a convenient solution for occasional constipation, providing on-the-go ease with its ready-to-drink suspension format. Tailored for adults and children over 8 years old, ForlaxGO features macrogol as its primary component, delivering a natural sense of relief. Its standout characteristic lies in the presentation as a pre-measured, single-dose sachet, offering a hassle-free, ready-to-use solution. Significantly, ForlaxGO is available over-the-counter at pharmacies, eliminating the need for a prescription. This strategic approach to product innovation underscores the commitment of major companies to meet evolving consumer needs in the constipation treatment market.

In March 2023, Ipsen, a pharmaceutical company headquartered in France, completed the acquisition of Albireo Pharma Inc. The specific financial details of this acquisition were not disclosed. Ipsen's strategic acquisition of Albireo Pharma Inc. signifies a move to enhance its portfolio within the realm of rare diseases. Albireo Pharma Inc., based in the United States, specializes in biotechnology and focuses on the development of medications targeting chronic constipation treatment. This acquisition is expected to strengthen Ipsen's presence and offerings in the field of rare disease therapeutics, particularly in addressing chronic constipation-related treatments and solutions.

Major companies operating in the constipation treatment market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Fresenius Kabi AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Ltd., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals, Bausch Health Companies Inc., Eisai Co. Ltd., Shionogi & Co. Ltd., Mallinckrodt Plc, Salix Pharmaceuticals Inc., Prestige Consumer Healthcare Inc., Taiho Pharmaceutical Co. Ltd., Ironwood Pharmaceuticals Inc., Cosmo Pharmaceuticals NV, Ferring Pharmaceuticals, RedHill Biopharma Ltd., Probi AB, 4D Pharma plc

North America was the largest region in the constipation treatment market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the constipation treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the constipation treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The constipation treatment market consists of sales of polyethylene glycol, bisacodyl, tegaserod, lubiprostone, and senna. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Constipation Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on constipation treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for constipation treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The constipation treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Therapeutic Types: Laxatives; Chloride Channel Activators; Peripherally Acting Mu-Opioid Receptor Antagonists; GC-C (Guanylate Cyclase-C) Agonists; Other Therapeutics
• 2) By Disease Type: Chronic Idiopathic Constipation (CIC); Irritable Bowel Syndrome With Constipation (IBS-C); Opioid-Induced Constipation (OIC)
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Laxatives: Osmotic Laxatives; Stimulant Laxatives; Bulk-Forming Laxatives; Stool Softeners; Chloride Channel Activators
• 2) By Chloride Channel Activators: Lubiprostone; Other Chloride Channel Activators
• 3) By Peripherally Acting Mu-Opioid Receptor Antagonists: Methylnaltrexone; Naloxegol; Other Mu-Opioid Receptor Antagonists
• 4) By GC-C (Guanylate Cyclase-C) Agonists: Plecanatide; Linaclotide
• 5) By Other Therapeutics: Probiotics; Dietary Supplements; Other Emerging Therapies
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bayer AG; Novartis AG; Merck & Co. Inc.; Sanofi S.A.; AstraZeneca plc; Fresenius Kabi AG; GlaxoSmithKline plc; Takeda Pharmaceutical Company Ltd.; Boehringer Ingelheim International GmbH; Regeneron Pharmaceuticals; Bausch Health Companies Inc.; Eisai Co. Ltd.; Shionogi & Co. Ltd.; Mallinckrodt Plc; Salix Pharmaceuticals Inc.; Prestige Consumer Healthcare Inc.; Taiho Pharmaceutical Co. Ltd.; Ironwood Pharmaceuticals Inc.; Cosmo Pharmaceuticals NV; Ferring Pharmaceuticals; RedHill Biopharma Ltd.; Probi AB; 4D Pharma plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Constipation Treatment Market Characteristics

3. Constipation Treatment Market Trends And Strategies

4. Constipation Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Constipation Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Constipation Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Constipation Treatment Market Growth Rate Analysis
• 5.4. Global Constipation Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Constipation Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Constipation Treatment Total Addressable Market (TAM)

6. Constipation Treatment Market Segmentation

• 6.1. Global Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laxatives
• Chloride Channel Activators
• Peripherally Acting Mu-Opioid Receptor Antagonists
• GC-C (Guanylate Cyclase-C) Agonists
• Other Therapeutics
• 6.2. Global Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Idiopathic Constipation (CIC)
• Irritable Bowel Syndrome With Constipation (IBS-C)
• Opioid-Induced Constipation (OIC)
• 6.3. Global Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Constipation Treatment Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Osmotic Laxatives
• Stimulant Laxatives
• Bulk-Forming Laxatives
• Stool Softeners
• Chloride Channel Activators
• 6.5. Global Constipation Treatment Market, Sub-Segmentation Of Chloride Channel Activators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lubiprostone
• Other Chloride Channel Activators
• 6.6. Global Constipation Treatment Market, Sub-Segmentation Of Peripherally Acting Mu-Opioid Receptor Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Methylnaltrexone
• Naloxegol
• Other Mu-Opioid Receptor Antagonists
• 6.7. Global Constipation Treatment Market, Sub-Segmentation Of GC-C (Guanylate Cyclase-C) Agonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plecanatide
• Linaclotide
• 6.8. Global Constipation Treatment Market, Sub-Segmentation Of Other Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Probiotics
• Dietary Supplements
• Other Emerging Therapies

7. Constipation Treatment Market Regional And Country Analysis

• 7.1. Global Constipation Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Constipation Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Constipation Treatment Market

• 8.1. Asia-Pacific Constipation Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Constipation Treatment Market

• 9.1. China Constipation Treatment Market Overview
• 9.2. China Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Constipation Treatment Market

• 10.1. India Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Constipation Treatment Market

• 11.1. Japan Constipation Treatment Market Overview
• 11.2. Japan Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Constipation Treatment Market

• 12.1. Australia Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Constipation Treatment Market

• 13.1. Indonesia Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Constipation Treatment Market

• 14.1. South Korea Constipation Treatment Market Overview
• 14.2. South Korea Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Constipation Treatment Market

• 15.1. Western Europe Constipation Treatment Market Overview
• 15.2. Western Europe Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Constipation Treatment Market

• 16.1. UK Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Constipation Treatment Market

• 17.1. Germany Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Constipation Treatment Market

• 18.1. France Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Constipation Treatment Market

• 19.1. Italy Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Constipation Treatment Market

• 20.1. Spain Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Constipation Treatment Market

• 21.1. Eastern Europe Constipation Treatment Market Overview
• 21.2. Eastern Europe Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Constipation Treatment Market

• 22.1. Russia Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Constipation Treatment Market

• 23.1. North America Constipation Treatment Market Overview
• 23.2. North America Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Constipation Treatment Market

• 24.1. USA Constipation Treatment Market Overview
• 24.2. USA Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Constipation Treatment Market

• 25.1. Canada Constipation Treatment Market Overview
• 25.2. Canada Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Constipation Treatment Market

• 26.1. South America Constipation Treatment Market Overview
• 26.2. South America Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Constipation Treatment Market

• 27.1. Brazil Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Constipation Treatment Market

• 28.1. Middle East Constipation Treatment Market Overview
• 28.2. Middle East Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Constipation Treatment Market

• 29.1. Africa Constipation Treatment Market Overview
• 29.2. Africa Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Constipation Treatment Market Competitive Landscape And Company Profiles

• 30.1. Constipation Treatment Market Competitive Landscape
• 30.2. Constipation Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Constipation Treatment Market Other Major And Innovative Companies

• 31.1. Merck & Co. Inc.
• 31.2. Sanofi S.A.
• 31.3. AstraZeneca plc
• 31.4. Fresenius Kabi AG
• 31.5. GlaxoSmithKline plc
• 31.6. Takeda Pharmaceutical Company Ltd.
• 31.7. Boehringer Ingelheim International GmbH
• 31.8. Regeneron Pharmaceuticals
• 31.9. Bausch Health Companies Inc.
• 31.10. Eisai Co. Ltd.
• 31.11. Shionogi & Co. Ltd.
• 31.12. Mallinckrodt Plc
• 31.13. Salix Pharmaceuticals Inc.
• 31.14. Prestige Consumer Healthcare Inc.
• 31.15. Taiho Pharmaceutical Co. Ltd.

32. Global Constipation Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Constipation Treatment Market

34. Recent Developments In The Constipation Treatment Market

35. Constipation Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Constipation Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Constipation Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Constipation Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer